Cerebrospinal Fluid Neurochemical Phenotypes in Vascular Dementias: Original Data and Mini-Review
Authors:
- Mirko BiblMBMirko Bibl
- Brit MollenhauerBMBrit Mollenhauer
- Hermann EsselmannHEHermann Esselmann
- Michael SchneiderMSMichael Schneider
- Piotr LewczukPLPiotr Lewczuk
- Volker WelgeVWVolker Welge
- Martin GrossMGMartin Gross
- Peter FalkaiPFPeter Falkai
- Johannes KornhuberJKJohannes Kornhuber
- Jens WiltfangJWJens Wiltfang
- 13 February 2008
- journal article
- review article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 25 (3) , 256-265
Abstract
Background/Aims: The study evaluated the patterns of cerebrospinal fluid (CSF), amyloid-β (Aβ) peptides, total tau and phospho-tau among Alzheimer’s disease (AD) and vascular dementias (VAD). Methods: Aβ-SDS-PAGE immunoblot and commercially available ELISAs were applied to the CSF analysis of 52 patients with probable (n = 21) and possible (n = 16) VAD, AD with cerebrovascular disease (n = 15), 30 patients with probable AD and 30 nondemented disease controls. Results: AD and AD with cerebrovascular disease displayed a similar neurochemical phenotype in contrast to nondemented disease controls and probable VAD with regard to tau, p-tau, Aβ1–40ox and Aβ1–42%. Possible VAD displayed AD-like changes only for Aβ1–40ox and Aβ1–42%. Conclusion: CSF neurochemical phenotypes sufficiently discriminate probable AD and VAD from each other, but their diagnostic value is limited in case of no clear-cut clinical appearance, such as possible VAD. Conversely, CSF Aβ peptides and p-tau levels may help estimate the involvement of AD-like pathophysiological pathways in VAD subgroups.Keywords
This publication has 44 references indexed in Scilit:
- The enigma of vascular cognitive disorder and vascular dementiaActa Neuropathologica, 2007
- CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodiesJournal of Neural Transmission, 2006
- CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementiaBrain, 2006
- Cerebrospinal fluid protein biomarkers for Alzheimer’s diseaseNeuroRX, 2004
- Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activitiesProceedings of the National Academy of Sciences, 1996
- Diagnostic accuracy of Alzheimer’s disease: A clinicopathological studyActa Neuropathologica, 1996
- New criteria for the diagnosis of vascular dementiaNeurology, 1993
- Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment CentersNeurology, 1992
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984